RXO stock faces a USD 5.8 billion takeover offer

Published on 10/08/2026 at 00:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RXO stock was last at USD 28.36 on October 7, 2026, after C.H. Robinson agreed to a USD 5.8 billion takeover. The offer implies USD 30.25 per share.

RXO, US74982T1034, Illustration mit AI erstellt.

RXO stock (ISIN US74982T1034) was last at USD 28.36 on the NYSE on October 7, 2026, down 0.63 percent from the prior close. The central issue is now C.H. Robinson's proposed USD 5.8 billion acquisition, which values each RXO share at USD 30.25 under the announced terms.

Takeover terms set the benchmark

According to C.H. Robinson on October 5, 2026, RXO shareholders would receive USD 17.25 in cash and 0.0856 C.H. Robinson shares for each RXO share. The transaction represents a 29 percent premium to RXO's October 2 closing price, although the stock component means the final value can change with C.H. Robinson's share price.

The agreement is expected to close in the first half of 2027 and remains subject to regulatory clearance and approval by RXO shareholders, according to Reuters on October 5, 2026. C.H. Robinson expects USD 300 million in net run-rate cost synergies within two years after closing, while RXO shareholders are expected to own 11 percent of the combined company.

Quarterly revenue rose 25 percent

RXO's latest reported quarter ended June 30, 2026. The company posted USD 1.77 billion in revenue and adjusted EPS of USD 0.06, compared with consensus revenue of USD 1.63 billion and consensus EPS of USD 0.04, according to MarketBeat. Revenue increased 25.0 percent from the year-earlier quarter, while the company reported a GAAP net loss of USD 9 million.

For investors assessing the offer, the operating comparison matters because the acquisition premium is tied to a business that is growing revenue while still reporting a GAAP loss. The transaction therefore shifts attention from standalone earnings to approval risk, the stock component and the delivery of the planned synergies.

Analyst targets sit below the offer

Consensus coverage remained Hold across 19 analysts, with 7 Buy ratings, 10 Hold ratings and 2 Sell ratings. The average price target was USD 24.84, with forecasts ranging from USD 13 to USD 35, according to TradingView. Truist Securities raised its target from USD 28 to USD 30 and assigned a Buy rating on October 7, 2026, as reported by GuruFocus.

RXO stock remains near its yearly high

RXO stock was last at USD 28.36 on October 7, 2026 at 4:00 p.m. ET. Its 52-week range was USD 10.43 to USD 29.90, and market capitalization stood at USD 4.7 billion, with 4,745,563 shares traded during the session.